Name: Clostridium Difficile Infection, an Issue of Infectious Disease Clinics of North America de Mark h. Wilcox(Elsevier Health (Textbook)) (en Inglés)
Price: 298666.00 COP
Availability: InStock
Author: Wilcox Mark H.
ISBN: 9780323356572

portada Clostridium Difficile Infection, an Issue of Infectious Disease Clinics of North America de Mark h. Wilcox(Elsevier Health (Textbook)) (en Inglés)

Formato

Libro Físico

Editorial

Elsevier Health (Textbook)

Autor

Wilcox Mark H.

Idioma

Inglés

Encuadernación

Tapa Dura

ISBN13

9780323356572

Clostridium Difficile Infection, an Issue of Infectious Disease Clinics of North America de Mark h. Wilcox(Elsevier Health (Textbook)) (en Inglés)

Wilcox Mark H. (Autor) · Elsevier Health (Textbook) · Tapa Dura

Libro Nuevo

$ 298.666

$ 497.777

Ahorras: $ 199.111

40% descuento

Envío normal

Origen: Reino Unido (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Jueves 04 de Julio y el Viernes 12 de Julio.

Lo recibirás en cualquier lugar de Colombia entre 1 y 5 días hábiles luego del envío.

Reseña del libro "Clostridium Difficile Infection, an Issue of Infectious Disease Clinics of North America de Mark h. Wilcox(Elsevier Health (Textbook)) (en Inglés)"

This issue of Infectious Disease Clinics of North America, guest edited by Dr. Mark H. Wilcox, is devoted to Clostridium Difficile Infection. Articles in this issue include: Potential sources of C. difficile for human infection; Colonisation versus carriage of C. difficile; Diagnostic pitfalls in C. difficile infection; The epidemiology of C. difficile infection in and outside of healthcare institutions; What makes epidemic C. difficile strains epidemic?: Fact versus fiction; Environmental interventions to control C. difficile infection; The contribution of strains and hosts to outcomes in C. difficile infection; Treatment of C. difficile infection; Faecal microbiota transplantation for the management of C. difficile infection; The morbidity, mortality, and costs associated with C. difficile infection; The potential of probiotics to prevent C. difficile infection; The prospect for vaccines to prevent C. difficile infection; and Predictive value of models of C. difficile infection.